And still a very small mc for a drug that has been proven to work across a large number of patients in ph3. After we chase cdoyles valuations we then look to the very large market potential of this drug. I struggle to understand the company pressos TAM as it feels too large to seriously discuss without feeling silly. So instead I take 50% off and its still massive which is why im holding long to see where this goes.
Ann: Dimerix and Taiba enter into License Agreement for DMX-200, page-23
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $242.0M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 46.5¢ | 44.0¢ | $1.428M | 3.181M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 109582 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 21213 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |